THE EFFECT OF CIPROHEPTADINE ON SOME RISK FACTORS FOR COMORBID DISEASES
Keywords:
blood pressure, hyperglycemia, cortisol, insulinAbstract
The article analyzes the results of a study of the effect of cortisol on some hemodynamic and carbohydrate metabolism indices. A group of patients suffering from metabolic syndrome identified according to the IDF criteria (2005) was observed. At the time of the study, the patients were aged 40– 59 years (mean age 54 years). Cyproheptadine was prescribed to reduce cortisol levels. The observation lasted 14 days. It was shown that against the background of cyproheptadine use, there is a decrease in the level of endogenous cortisol, blood pressure, glycemia, and immunoreactive insulin.
References
Shankar R, Marston XL, Danielson V, Do
Rego B, Lasagne R, Williams O, Groves L.
Real-world evidence of epidemiology,
patient characteristics, and mortality in
people with drug-resistant epilepsy in the
United Kingdom, 2011-2021. J Neurol.
May;271(5):2473-2483. doi:
1007/s00415-023-12165-4. Epub 2024
Jan 19. PMID: 38240828; PMCID:
PMC11055725.
Prevention or Delay of Diabetes and
Associated Comorbidities: Standards of
Care in Diabetes—2024. American
Diabetes Association Professional Practice
Committee. Diabetes Care
;47(Supplement_1):S43–S51
Kovesdy CP. Epidemiology of chronic
kidney disease: an update 2022. Kidney
Int Suppl (2011). 2022 Apr;12(1):7-11.
doi: 10.1016/j.kisu.2021.11.003. Epub
Mar 18. PMID: 35529086; PMCID:
PMC9073222.
Shankar R, Marston XL, Danielson V, Do
Rego B, Lasagne R, Williams O, Groves L.
Real-world evidence of epidemiology,
patient characteristics, and mortality in
people with drug-resistant epilepsy in the
United Kingdom, 2011-2021. J Neurol.
May;271(5):2473-2483. doi:
1007/s00415-023-12165-4. Epub 2024
Jan 19. PMID: 38240828; PMCID:
PMC11055725.
Kovesdy CP. Epidemiology of chronic
kidney disease: an update 2022. Kidney
Int Suppl (2011). 2022 Apr;12(1):7-11.
doi: 10.1016/j.kisu.2021.11.003. Epub
Mar 18. PMID: 35529086; PMCID:
PMC90732226. Robert Fraser, Mary C. Ingram, Niall H.
Anderson, Caroline Morrison, Eleanor
Davies, and John M. C. ConnellAuthor Info
& Affiliations. Cortisol Effects on Body
Mass, Blood Pressure, and Cholesterol in
the General Population. Hypertension.
; 33(6): 1364–1368. doi:
1161/01.HYP.33.6.13
Whitworth JA, Williamson PM, Mangos G,
Kelly JJ. Cardiovascular consequences of
cortisol excess. Vasc Health Risk Manag.
;1(4):291-9. doi:
2147/vhrm.2005.1.4.291. PMID:
; PMCID: PMC1993964.
Min L. Functional hypercortisolism, visceral
obesity, and metabolic syndrome. Endocr
Pract. 2016 Apr;22(4):506-8. doi:
4158/EP161197.CO. Epub 2016 Jan 20.
PMID: 26789349; PMCID: PMC4837456.
Sekhon S, Gupta V. Mood Disorder.
[Updated 2023 May 8]. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls
Publishing; 2024 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK5
/
Thorpe, K.J., Pattinson, C.L., Smith, S.S. et
al. Mandatory Naptimes in Childcare do
not Reduce Children’s Cortisol Levels. Sci
Rep 8, 4545 (2018). doi.: 10.1038/s41598-
-22555-8
Volkow ND, Blanco C. Substance use
disorders: a comprehensive update of
classification, epidemiology, neurobiology,
clinical aspects, treatment and prevention.
World Psychiatry. 2023 Jun;22(2):203-229.
doi: 10.1002/wps.21073. PMID:
; PMCID: PMC10168177.
Popescu ER, Semeniuc S, Hritcu LD,
Horhogea CE, Spataru MC, Trus C, Dobrin
RP, Chirita V, Chirita R. Cortisol and
Oxytocin Could Predict Covert Aggression
in Some Psychotic Patients. Medicina.
; 57(8):760. doi:
3390/medicina57080760/
Sonino N., Boscaro M. Medical therapy for
Cushing's disease. Endocrinol Metab Clin
North Am. 1999;28(1):211-222.
Trainer P.J., Grossman A.B. The diagnosis
and management of Cushing's syndrome.
Endocrinol Metab Clin North Am.
;24(4):841-862.
Gillman P.K. Serotonin syndrome: history,
pathophysiology, and diagnosis. CNS Drug
Reviews. 1999;5(4):347-366.
Nieman L.K., Biller B.M., Findling J.W., et
al. The diagnosis of Cushing's syndrome:
an Endocrine Society Clinical Practice
Guideline. J Clin Endocrinol Metab.
;93(5):1526-1540.
MedCalc® Statistical Software version
023 (MedCalc Software Ltd, Ostend,
Belgium; https://www.medcalc.org; 2024).
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
